Early use of airway pressure release ventilation in acute respiratory distress syndrome induced by coronavirus disease 2019: a case report

Journal of Medical Case Reports

Case Report

Hori Hariyanto¹  Jadeny Sinatra²  Ronnie Wirawan Salim³  Epifanus Arie Tanoto³ 

[1] Anesthesiology Department and Critical Care Medicine, Siloam Hospital Lippo Village, Tangerang, Banten, Indonesia;Department of Anesthesiology, Faculty of Medicine, Universitas Methodist Indonesia, Medan, Sumatera Utara, Indonesia;Anesthesiology Department, Siloam Dhirga Surya Hospital, Medan, Sumatera Utara, Indonesia;Emergency Department, Siloam Dhirga Surya Hospital, Medan, Sumatera Utara, Indonesia;

关键词: Airway pressure release ventilation;    COVID-19;    Acute respiratory distress syndrome;    Case report;   

DOI  :  10.1186/s13256-022-03658-3

 received in 2021-11-01, accepted in 2022-10-27,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundCoronavirus disease 2019 is a highly transmissible and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2, a novel coronavirus that was identified in early January 2020 in Wuhan, China, and has become a pandemic disease worldwide. The symptoms of coronavirus disease 2019 range from asymptomatic to severe respiratory failure. In moderate and severe cases, oxygen therapy is needed. In severe cases, high-flow nasal cannula, noninvasive ventilation, and invasive mechanical ventilation are needed. Many ventilation methods in mechanical ventilation can be used, but not all are suitable for coronavirus disease 2019 patients. Airway pressure release ventilation, which is one of the mechanical ventilation methods, can be considered for patients with moderate-to-severe acute respiratory distress syndrome. It was found that oxygenation in the airway pressure release ventilation method was better than in the conventional method. How about airway pressure release ventilation in coronavirus disease 2019 patients? We report a case of confirmed coronavirus disease 2019 in which airway pressure release ventilation mode was used.Case presentationIn this case study, we report a 74-year-old Chinese with a history of hypertension and uncontrolled diabetes mellitus type 2. He came to our hospital with the chief complaint of difficulty in breathing. He was fully awake with an oxygen saturation of 82% on room air. The patient was admitted and diagnosed with severe coronavirus disease 2019, and he was given a nonrebreathing mask at 15 L per minute, and oxygen saturation went back to 95%. After a few hours with a nonrebreathing mask, his condition worsened. On the third day after admission, saturation went down despite using noninvasive ventilation. We decided to intubate the patient and used airway pressure release ventilation mode. Finally, after 14 days of being intubated, the patient could be extubated and discharged after 45 days of hospitalization.ConclusionEarly use of airway pressure release ventilation may be considered as one of the ventilation strategies to treat severe coronavirus disease 2019 acute respiratory distress syndrome. Although reports on airway pressure release ventilation and protocols on its initiation and titration methods are limited, it may be worthwhile to consider, given its known ability to maximize alveolar recruitment, preserve alveolar epithelial integrity, and surfactant, all of which are crucial for handling the “fragile” lungs of coronavirus disease 2019 patients.

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

12888_2022_4365_Article_IEq28.gif

12888_2022_4365_Article_IEq24.gif

12888_2022_4365_Article_IEq12.gif